-
Salvianolic Acid B and the Mechanics of Fibrosis
2026-09-24
Salvianolic acid B offers translational researchers a way to investigate fibrosis beyond collagen abundance: by asking whether LH2-associated cross-linking helps make the extracellular matrix self-reinforcing. This article examines the evidence, practical validation strategies, and the limits that matter when moving from a natural-product signal to a credible research hypothesis.
-
O-GlcNAc–HUWE1–TfR1 Axis in Preeclampsia
2026-09-23
The reference study identifies an O-GlcNAc–HUWE1–TfR1 pathway that links placental nutrient sensing to iron handling, ferroptosis, and trophoblast syncytialization in preeclampsia. Its findings suggest that stabilizing HUWE1 through O-GlcNAc modification can reduce TfR1-dependent iron uptake and improve adverse pregnancy phenotypes, while also defining important experimental limits for therapeutic translation.
-
Annexin V-FITC/PI Apoptosis Assay Kit Guide
2026-09-23
The Annexin V-FITC/PI Apoptosis Assay Kit helps researchers separate viable, early apoptotic, and membrane-compromised cell populations using phosphatidylserine binding and PI exclusion. It is suitable for research flow cytometry or fluorescence microscopy, but it is not a diagnostic test and cannot independently identify every cell-death mechanism.
-
AZD6482: Selective PI3Kβ Inhibitor Guide
2026-09-22
AZD6482 is an ATP-competitive PI3Kβ inhibitor with strong isoform selectivity and reported activity in platelet and adipocyte models. This guide separates product-level benchmarks from the distinct HSP90–DM1 RNA-foci evidence base and defines practical experimental limits.
-
gamma-Glu-Cys Workflows for Glutathione Research
2026-09-21
Build more interpretable glutathione synthetase assays, peptide-synthesis screens, and microbial comparisons with a defined γ-Glu-Cys starting material. This guide combines product handling, literature-informed assay design, and troubleshooting for matrix-sensitive glutathione metabolism research.
-
Oligo-dT Membrane Design for mRNA Capture
2026-09-21
The reference study establishes design rules for improving oligo-dT affinity membranes by controlling ligand density, clustering, length, and pore size. Its local-density model and super-resolution measurements connect nanoscale ligand organization with full-length mRNA capture, providing a practical framework for reducing steric exclusion and ligand wastage.
-
JHU-083: A Translational Lens on Glutaminase
2026-09-20
JHU-083 is a 6-diazo-5-oxo-L-norleucine precursor that enables targeted glutaminase pathway research in cerebral CD11b cells and experimental cerebral malaria models. This thought-leadership article connects glutamate biology with redox-centered translational strategy, using recent GSTA1 hepatotoxicity findings to define opportunities, controls, and limitations without overstating cross-domain evidence.
-
Separating Growth Arrest from Cell Death in Cancer
2026-09-19
Schwartz’s 2022 dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its central contribution is a framework for distinguishing proliferative arrest from cell killing, including their different proportions and temporal dynamics, thereby improving assay interpretation and experimental design in cancer research.
-
DAPI Solution (1 mg/mL): Mechanism & Use
2026-09-19
DAPI, or 4',6-Diamidino-2-Phenylindole, is a blue-fluorescent DNA stain for nuclear visualization and membrane-integrity assessment. The 1 mg/mL DMSO stock supports microscopy and flow cytometry workflows, but DAPI positivity alone does not establish apoptosis.
-
DAMGO in µ-Opioid Receptor Signaling
2026-09-18
DAMGO is a selective µ-opioid receptor agonist for connecting receptor-proximal assays with tissue physiology and pain-circuit studies. This workflow-focused guide covers concentration planning, storage controls, assay selection, and interpretation of paradoxical mechanical hypersensitivity findings.
-
ATF6 Proteostasis Rescue of Pathogenic GABAA Receptors
2026-09-18
Wang et al. show that pharmacological activation of ATF6 can remodel endoplasmic-reticulum proteostasis and improve the assembly, trafficking, surface expression, and activity of pathogenic GABAA receptors. The study supports proteostasis enhancement as a mutation-spanning strategy, while also highlighting the need to distinguish increased surface abundance from complete restoration of neuronal function.
-
Batimastat (BB-94) in Protease-Driven Assays
2026-09-17
Batimastat (BB-94) provides a rigorous way to investigate extracellular MMP activity across tumor and neuromuscular models. This article translates its zinc-chelating mechanism and broad potency into assay-design decisions inspired by spatially localized BDNF processing at developing synapses.
-
Oteseconazole (VT-1161) Research Workflows
2026-09-17
Oteseconazole (VT-1161) gives Candida researchers a concentration-controlled way to study fungal CYP51, from broth microdilution to resistant-isolate profiling. This practical guide separates established product properties from assay starting points and translates a 2025 deuterated-inhibitor study into actionable experimental choices.
-
Gepotidacin for Uncomplicated Gonorrhea: Phase 2 Findings
2026-09-16
This phase 2 randomized study evaluated whether a single oral dose of gepotidacin could eradicate uncomplicated urogenital Neisseria gonorrhoeae infections. Both dose groups produced at least 95% microbiological eradication, while the few failures were associated with a shared mutation and the highest observed gepotidacin MIC, highlighting both the promise of a nontraditional antibacterial target and the need for resistance surveillance.
-
(-)-Norepinephrine (+)-bitartrate Workflows
2026-09-15
Build more reproducible adrenergic assays and cardiovascular models with a workflow that separates salt-form calculations, receptor biology, and exposure timing. The approach also translates clinical vasopressor-conversion evidence into practical reporting and troubleshooting choices without treating a bedside ratio as an in vitro dose.